药品注册申请号:019614
申请类型:NDA (新药申请)
申请人:AZURITY
申请人全名:AZURITY PHARMACEUTICALS INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 VERELAN VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 120MG Yes No AB 1990/05/29 1990/05/29 Prescription
002 VERELAN VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 240MG Yes No AB 1990/05/29 Prescription
003 VERELAN VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 180MG Yes No AB 1992/01/09 Prescription
004 VERELAN VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 360MG Yes Yes None 1996/05/10 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2019/10/01 SUPPL-56(补充) Approval Labeling STANDARD
2016/11/18 SUPPL-53(补充) Approval Labeling STANDARD
2014/10/09 SUPPL-50(补充) Approval Labeling UNKNOWN
2011/11/14 SUPPL-49(补充) Approval Labeling UNKNOWN
2010/03/30 SUPPL-45(补充) Approval Labeling UNKNOWN
2010/03/30 SUPPL-34(补充) Approval Labeling STANDARD
2000/11/29 SUPPL-32(补充) Approval Manufacturing (CMC) STANDARD
2000/07/27 SUPPL-31(补充) Approval Manufacturing (CMC) STANDARD
1999/12/13 SUPPL-30(补充) Approval Manufacturing (CMC) STANDARD
1999/07/02 SUPPL-28(补充) Approval Manufacturing (CMC) STANDARD
1999/06/05 SUPPL-27(补充) Approval Labeling STANDARD
1998/10/15 SUPPL-26(补充) Approval Manufacturing (CMC) STANDARD
1998/07/14 SUPPL-24(补充) Approval Labeling STANDARD
1997/12/30 SUPPL-23(补充) Approval Manufacturing (CMC) STANDARD
1997/07/29 SUPPL-25(补充) Approval Labeling STANDARD
1997/04/23 SUPPL-22(补充) Approval Manufacturing (CMC) STANDARD
1996/05/31 SUPPL-20(补充) Approval Manufacturing (CMC) STANDARD
1996/05/31 SUPPL-19(补充) Approval Manufacturing (CMC) STANDARD
1996/05/16 SUPPL-18(补充) Approval Manufacturing (CMC) STANDARD
1996/05/10 SUPPL-13(补充) Approval Manufacturing (CMC) STANDARD
1996/02/01 SUPPL-17(补充) Approval Manufacturing (CMC) STANDARD
1995/08/02 SUPPL-16(补充) Approval Manufacturing (CMC) STANDARD
1995/06/21 SUPPL-11(补充) Approval Labeling STANDARD
1994/10/12 SUPPL-6(补充) Approval Labeling
1994/08/18 SUPPL-2(补充) Approval Manufacturing (CMC) STANDARD
1994/04/05 SUPPL-1(补充) Approval Manufacturing (CMC) STANDARD
1994/03/30 SUPPL-10(补充) Approval Manufacturing (CMC) STANDARD
1993/12/06 SUPPL-9(补充) Approval Labeling STANDARD
1993/11/08 SUPPL-12(补充) Approval Labeling STANDARD
1992/10/02 SUPPL-8(补充) Approval Labeling
1992/10/02 SUPPL-7(补充) Approval Labeling
1992/01/09 SUPPL-3(补充) Approval Manufacturing (CMC) STANDARD
1991/09/13 SUPPL-5(补充) Approval Labeling
1991/06/06 SUPPL-4(补充) Approval Labeling
1990/05/29 ORIG-1(原始申请) Approval Type 3 - New Dosage Form STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
001 4863742 2007/06/19 U-3 PDF格式**本条是由Drugfuture回溯的历史信息**
002 4863742 2007/06/19 U-3 PDF格式**本条是由Drugfuture回溯的历史信息**
003 4863742 2007/06/19 U-3 PDF格式**本条是由Drugfuture回溯的历史信息**
004 4863742 2007/06/19 PDF格式**本条是由Drugfuture回溯的历史信息**
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:VERAPAMIL HYDROCHLORIDE 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL 规格:120MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
019614 001 NDA VERELAN VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 120MG Prescription Yes No AB 1990/05/29 AZURITY
075138 001 ANDA VERAPAMIL HYDROCHLORIDE VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 120MG Prescription No No AB 1999/04/20 MYLAN
活性成分:VERAPAMIL HYDROCHLORIDE 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL 规格:240MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
019614 002 NDA VERELAN VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 240MG Prescription Yes No AB 1990/05/29 AZURITY
075138 003 ANDA VERAPAMIL HYDROCHLORIDE VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 240MG Prescription No No AB 1999/04/20 MYLAN
活性成分:VERAPAMIL HYDROCHLORIDE 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL 规格:180MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
019614 003 NDA VERELAN VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 180MG Prescription Yes No AB 1992/01/09 AZURITY
075138 002 ANDA VERAPAMIL HYDROCHLORIDE VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 180MG Prescription No No AB 1999/04/20 MYLAN
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database